{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T11:25:47Z","timestamp":1793273147341,"version":"4.5.0"},"reference-count":50,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,7,21]],"date-time":"2025-07-21T00:00:00Z","timestamp":1753056000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Ulcerative colitis (UC) is characterized by aberrant immune responses involving multiple inflammatory pathways, including JAK\/STAT signaling. However, the specific roles and interactions of individual components within this pathway remain unclear.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We conducted a prospective, observational, single-center study enrolling 61 adult UC patients undergoing routine colonoscopy with endoscopic activity (Mayo Endoscopic Score &amp;gt; 0). Paired biopsies from inflamed and non-inflamed colonic mucosa were collected. Phosphorylation levels of JAK1, JAK2, JAK3, TYK2, STAT1, STAT3, and STAT4 were quantified by Western blot.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Inflamed tissue showed significantly increased phosphorylation of JAK2, JAK3, TYK2, STAT1, STAT3, and STAT4 compared to non-inflamed mucosa (p &amp;lt; 0.05), while JAK1 levels did not differ significantly. Correlation analysis revealed coordinated activation among JAK2, JAK3, TYK2, and STAT3, suggesting interdependent roles. Notably, male patients exhibited significantly higher activation of JAK2 and STAT3 than female patients (p &amp;lt; 0.05).<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion<\/jats:title><jats:p>These findings highlight a heterogeneous but important involvement of the JAK\/STAT pathway in UC pathophysiology. The observed sex-specific differences and coordinated activation patterns suggest the value of personalized therapeutic approaches targeting specific components of this pathway.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fimmu.2025.1609740","type":"journal-article","created":{"date-parts":[[2025,7,21]],"date-time":"2025-07-21T05:22:34Z","timestamp":1753075354000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":13,"title":["Exploration of JAK\/STAT pathway activation in ulcerative colitis reveals sex-dependent activation of JAK2\/STAT3 in the inflammatory response"],"prefix":"10.3389","volume":"16","author":[{"given":"Cristina","family":"Calvi\u00f1o-Su\u00e1rez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mari\u00f1a","family":"Dur\u00e1n-Rub\u00ed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"Brea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Moreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"In\u00e9s","family":"Ardao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iria","family":"Brocos-Mosquera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roc\u00edo","family":"Ferreiro-Iglesias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sol","family":"Porto-Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Nieto-Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Jos\u00e9","family":"Varela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Isabel","family":"Loza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ant\u00f3n L.","family":"Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Barreiro-de Acosta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,7,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.suc.2019.08.001","article-title":"Inflammatory bowel disease presentation and diagnosis","volume":"99","author":"Flynn","year":"2019","journal-title":"Surg Clinics North America"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjx008","article-title":"Third european evidence-based consensus on diagnosis and management of ulcerative colitis. Part 1: definitions, diagnosis, extra-intestinal manifestations, pregnancy, cancer surveillance, surgery, and ileo-anal pouch disorders","volume":"11","author":"Magro","year":"2017","journal-title":"J Crohns Colitis"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)32126-2","article-title":"Ulcerative colitis","volume":"389","author":"Ungaro","year":"2017","journal-title":"Lancet"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.gtc.2020.07.005","article-title":"Epidemiology and pathogenesis of ulcerative colitis","volume":"49","author":"Du","year":"2020","journal-title":"Gastroenterol Clin North Am"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.pmedr.2023.102173","article-title":"Inflammatory bowel disease prevalence: surveillance data from the U.S. National health and nutrition examination survey","volume":"33","author":"Weisman","year":"2023","journal-title":"Prev Med Rep"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1038\/nrgastro.2015.150","article-title":"The global burden of IBD: from 2015 to 2025","volume":"12","author":"Kaplan","year":"2015","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1606910","article-title":"Tofacitinib as induction and maintenance therapy for ulcerative colitis","volume":"376","author":"Sandborn","year":"2017","journal-title":"New Engl J Med"},{"key":"B8","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1056\/NEJMoa1215734","article-title":"Vedolizumab as induction and maintenance therapy for ulcerative colitis","volume":"369","author":"Feagan","year":"2013","journal-title":"New Engl J Med"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa050516","article-title":"Infliximab for induction and maintenance therapy for ulcerative colitis","volume":"353","author":"Rutgeerts","year":"2005","journal-title":"New Engl J Med"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(22)00581-5","article-title":"Upadacitinib as induction and maintenance therapy for moderately to severely active ulcerative colitis: results from three phase 3, multicentre, double-blind, randomised trials","volume":"399","author":"Danese","year":"2022","journal-title":"Lancet"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1515\/jbcpp-2018-0036","article-title":"Immune response and inflammatory pathway of ulcerative colitis","volume":"30","author":"Tatiya-aphiradee","year":"2018","journal-title":"J Basic Clin Physiol Pharmacol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/s41392-021-00791-1","article-title":"The JAK\/STAT signaling pathway: from bench to clinic","volume":"6","author":"Hu","year":"2021","journal-title":"Signal Transduct Target Ther"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.stemcr.2024.06.006","article-title":"JAK\/STAT signaling promotes the emergence of unique cell states in ulcerative colitis","volume":"19","author":"Maciag","year":"2024","journal-title":"Stem Cell Rep"},{"key":"B14","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s43556-023-00151-1","article-title":"JAK-STAT signaling in inflammation and stress-related diseases: implications for therapeutic interventions","volume":"4","author":"Sarapultsev","year":"2023","journal-title":"Mol Biomedicine"},{"key":"B15","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/s41392-023-01468-7","article-title":"Evolving cognition of the JAK-STAT signaling pathway: autoimmune disorders and cancer","volume":"8","author":"Xue","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2019-318448","article-title":"JAK selectivity for inflammatory bowel disease treatment: does it clinically matter","volume":"68","author":"Danese","year":"2019","journal-title":"Gut"},{"key":"B17","article-title":"Increased numbers of interleukin-15-expressing cells in active ulcerative colitis","volume":"91","author":"Kirman","year":"1996","journal-title":"Am J Gastroenterol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"890","DOI":"10.3892\/etm.2021.10322","article-title":"IL\u20116\/STAT3 signaling pathway regulates the proliferation and damage of intestinal epithelial cells in patients with ulcerative colitis via H3K27ac","volume":"22","author":"Li","year":"2021","journal-title":"Exp Ther Med"},{"key":"B19","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1186\/s12967-023-04326-w","article-title":"A precise molecular subtyping of ulcerative colitis reveals the immune heterogeneity and predicts clinical drug responses","volume":"21","author":"Mo","year":"2023","journal-title":"J Transl Med"},{"key":"B20","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1186\/s12876-024-03514-2","article-title":"Sex-related differences in profiles and clinical outcomes of Inflammatory bowel disease: a systematic review and meta-analysis","volume":"24","author":"Salem","year":"2024","journal-title":"BMC Gastroenterol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2001.22453","article-title":"Evidence for inflammatory bowel disease of a susceptibility locus on the X chromosome","volume":"120","author":"Vermeire","year":"2001","journal-title":"Gastroenterology"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.mad.2023.111797","article-title":"Sex differences in markers of oxidation and inflammation","volume":"211","author":"Mart\u00ednez de Toda","year":"2023","journal-title":"Implications ageing Mech Ageing Dev"},{"key":"B23","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1038\/nri2815","article-title":"The X chromosome in immune functions: when a chromosome makes the difference","volume":"10","author":"Libert","year":"2010","journal-title":"Nat Rev Immunol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1038\/nmeth.2089","article-title":"NIH Image to ImageJ: 25 years of image analysis","volume":"9","author":"Schneider","year":"2012","journal-title":"Nat Methods"},{"key":"B25","volume-title":"R: A language and environment for statistical computing","year":"2021"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v20.i28.9458","article-title":"Epidemiology, demographic characteristics and prognostic predictors of ulcerative colitis","volume":"20","author":"Da Silva","year":"2014","journal-title":"World J Gastroenterol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1091\/mbc.E14-12-1645","article-title":"Defining the functional binding sites of interleukin 12 receptor \u03b21 and interleukin 23 receptor to Janus kinases","volume":"27","author":"Floss","year":"2016","journal-title":"Mol Biol Cell"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2022.e10314","article-title":"ameliorates DSS-induced ulcerative colitis in mice through dual inhibition of NLRP3 inflammasome and IL-6\/JAK2\/STAT3 pathways","volume":"8","author":"Qin","year":"2022","journal-title":"Heliyon"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2021\/6618924","article-title":"Mucosal epithelial jak kinases in health and diseases","volume":"2021","author":"Kumar","year":"2021","journal-title":"Mediators Inflammation"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1003244","article-title":"Involvement of tyrosine kinase-2 in both the IL-12\/th1 and IL-23\/th17 axes","volume":"187","author":"Ishizaki","year":"2011","journal-title":"In Vivo J Immunol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1093\/ibd\/izab135","article-title":"Selective tyrosine kinase 2 inhibition for treatment of inflammatory bowel disease: new hope on the rise","volume":"27","author":"Danese","year":"2021","journal-title":"Inflammation Bowel Dis"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1097\/00054725-200502000-00001","article-title":"Signal transducers and activators of transcription 3 signaling pathway","volume":"11","author":"Musso","year":"2005","journal-title":"Inflammation Bowel Dis"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1136\/gut.51.3.379","article-title":"Activation of signal transducer and activator of transcription (STAT) 1 in human chronic inflammatory bowel disease","volume":"51","author":"Schreiber","year":"2002","journal-title":"Gut"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellimm.2007.10.003","article-title":"Increased expression and activation of IL-12-induced Stat4 signaling in the mucosa of ulcerative colitis patients","volume":"248","author":"Pang","year":"2007","journal-title":"Cell Immunol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1097\/MIB.0000000000000180","article-title":"Stat3: friend or foe in colitis and colitis-associated cancer","volume":"20","author":"Han","year":"2014","journal-title":"Inflammation Bowel Dis"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2023.108402","article-title":"Selective JAK1 inhibitors for the treatment of inflammatory bowel disease","volume":"245","author":"Nielsen","year":"2023","journal-title":"Pharmacol Ther"},{"key":"B37","doi-asserted-by":"publisher","first-page":"e1224","DOI":"10.1002\/iid3.1224","article-title":"Investigating the association between the tissue expression of miRNA-101, JAK2\/STAT3 with TNF-\u03b1, IL-6, IL-1\u03b2, and IL-10 cytokines in the ulcerative colitis patients","volume":"12","author":"Voshagh","year":"2024","journal-title":"Immun Inflammation Dis"},{"key":"B38","article-title":"Therapeutic strategies for targeting the IL-6\/STAT3 cytokine signaling pathway in inflammatory bowel disease","volume":"27","author":"Mitsuyama","year":"2007","journal-title":"Anticancer Res"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2009.184176","article-title":"Disease-related expression of the IL6\/STAT3\/SOCS3 signalling pathway in ulcerative colitis and ulcerative colitis-related carcinogenesis","volume":"59","author":"Li","year":"2010","journal-title":"Gut"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1172\/JCI33194","article-title":"IL-22 ameliorates intestinal inflammation in a mouse model of ulcerative colitis","volume":"118","author":"Sugimoto","year":"2008","journal-title":"J Clin Invest"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.168.11.5699","article-title":"A receptor for the heterodimeric cytokine IL-23 is composed of IL-12R\u03b21 and a novel cytokine receptor subunit, IL-23R","volume":"168","author":"Parham","year":"2002","journal-title":"J Immunol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1084\/jem.181.1.399","article-title":"Interleukin 12 (IL-12) induces tyrosine phosphorylation of JAK2 and TYK2: differential use of Janus family tyrosine kinases by IL-2 and IL-12","volume":"181","author":"Bacon","year":"1995","journal-title":"J Exp Med"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1172\/JCI126567","article-title":"TYK2 inhibition reduces type 3 immunity and modifies disease progression in murine spondyloarthritis","volume":"130","author":"Gracey","year":"2020","journal-title":"J Clin Invest"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2007.135053","article-title":"IL23 differentially regulates the Th1\/Th17 balance in ulcerative colitis and Crohn\u2019s disease","volume":"57","author":"Kobayashi","year":"2008","journal-title":"Gut"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1055914","article-title":"The role of Th17 cells in inflammatory bowel disease and the research progress","volume":"13","author":"Chen","year":"2023","journal-title":"Front Immunol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1038\/nrclinonc.2018.8","article-title":"Targeting the IL-6\/JAK\/STAT3 signalling axis in cancer","volume":"15","author":"Johnson","year":"2018","journal-title":"Nat Rev Clin Oncol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s12079-022-00695-x","article-title":"Role of interleukin-6-mediated inflammation in the pathogenesis of inflammatory bowel disease: focus on the available therapeutic approaches and gut microbiome","volume":"17","author":"Shahini","year":"2023","journal-title":"J Cell Commun Signal"},{"key":"B48","doi-asserted-by":"publisher","first-page":"13504","DOI":"10.1038\/s41598-023-40744-y","article-title":"Biological sex is associated with heterogeneous responses to IL-6 receptor inhibitor treatment in COVID-19\u2014A retrospective cohort study","volume":"13","author":"Stein","year":"2023","journal-title":"Sci Rep"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1097\/TA.0b013e3181650fdf","article-title":"Male gender is associated with excessive IL-6 expression following severe injury","volume":"64","author":"Sperry","year":"2008","journal-title":"J Trauma: Injury Infection Crit Care"},{"key":"B50","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1053\/j.gastro.2010.02.007","article-title":"Inflammatory bowel disease confers a lower risk of colorectal cancer to females than to males","volume":"138","author":"S\u00f6derlund","year":"2010","journal-title":"Gastroenterology"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1609740\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,21]],"date-time":"2025-07-21T05:22:34Z","timestamp":1753075354000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1609740\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,21]]},"references-count":50,"alternative-id":["10.3389\/fimmu.2025.1609740"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1609740","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,21]]},"article-number":"1609740"}}